EntoZyme
PrivateLast Round
Seed
Oct 26, 2023
Total Funding Raised
$320,000
Company Overview
EntoZyme is a biotechnology company that develops genetic engineering techniques to process various organic waste streams and produce valuable enzymes and bioactive compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy, Sustainable Materials, Waste Management
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EntoZyme Comparables
Compare EntoZyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ByBug | 85% | |
| BugEra | 80% | |
| Schwarz Group | 78% | |
EntoZyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 26, 2023 |
EntoZyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Macquarie University Incubator | Seed |
| UNSW Founders | Seed |
| Main Sequence Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 145% MoM.
- Oct 26, 2023
$320K round led by Main Sequence Ventures.
EntoZyme Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EntoZyme's valuation, stock price, and market status.